1. RESEARCH HIGHLIGHT: Identifying miR-3662 as a new player in hematopoiesis and acute myeloid leukemia (AML)

    RESEARCH HIGHLIGHT: Identifying miR-3662 as a new player in hematopoiesis and acute myeloid leukemia (AML)
    SBI’s lentiviral reagents and miR services help researchers bridge the gap between GWAS and phenotype at a QTL involved in hematopoiesis and acute myeloid leukemia. Continue reading →

1 Item